| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/17/2007 | CN1895607A Extraction and its use for garlicin and garlic active component composition |
| 01/17/2007 | CN1895441A Medicament for treating mastopathy |
| 01/17/2007 | CN1895282A Calcium supplementary agent and its preparation |
| 01/17/2007 | CN1295332C Recombinant human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 01/17/2007 | CN1295330C Preparation method and use of high antiviral active recombination chicken gamma-interferon crCHIFN-gamma |
| 01/17/2007 | CN1295247C Ganoderma lucidum polysaccharide protein and its preparing method and use |
| 01/17/2007 | CN1294990C Composition of nanometer SOD and ginseng or its extract and its preparation method |
| 01/17/2007 | CN1294989C Composition of nanometer SOD and nano pueraria root and its preparation method |
| 01/17/2007 | CN1294988C Buckwheat trypsase inhibitor, expression and application thereof |
| 01/17/2007 | CN1294987C Use of cTn I in preparation of anticancer medicine |
| 01/17/2007 | CN1294986C Process for producing ampeptide element |
| 01/17/2007 | CN1294896C Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
| 01/17/2007 | CN1294848C Protein powder fat-reducing foodstuff with low heat quantity and balanced nutrition |
| 01/16/2007 | US7164012 Nucleic acids, expression vectors and host cells exhibiting the same peptidyl-prolyl isomerase activity as a Pin protein fragment; antimitotic agents |
| 01/16/2007 | US7164010 Metallothionein containing manganese and cadmium |
| 01/16/2007 | US7164009 Pro9821 polypeptides |
| 01/16/2007 | US7164008 Water soluble; binds toll-like receptors |
| 01/16/2007 | US7164007 Antitumor agents; anticancer agents; wound healing agents; cardiovascular disorders |
| 01/16/2007 | US7164005 Microencapsulation and sustained release of biologically active polypeptides |
| 01/16/2007 | US7164002 FVIIa antagonists |
| 01/16/2007 | US7164000 RANTES mutants and therapeutic applications thereof |
| 01/16/2007 | US7163933 Treating agent for Paget's disease of bone |
| 01/16/2007 | US7163923 Peptide deformylase activated prodrugs |
| 01/16/2007 | US7163922 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 01/16/2007 | US7163921 Peptide derivatives and medicinal compositions |
| 01/16/2007 | US7163920 Peptide with osteogenic activity |
| 01/16/2007 | US7163919 injecting into the tumor itself of a patient with a daily dose of between 1 and 5 mg of composition of citric acid, zinc, albumin and carrier |
| 01/16/2007 | US7163918 Attachment to carrier peptide; increasing absorption of through intestinal epithelia; bioavailability, reliability, sustained release |
| 01/16/2007 | US7163917 Synthesis method of alanylglutamine |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163817 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for their preparation |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163806 mammalian therapeutics free from prion contamination |
| 01/16/2007 | US7163805 Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein |
| 01/16/2007 | US7163802 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/16/2007 | US7163801 Diagnosing tumors by monitor concentration and expression of tumor up regulated card containing antagonist of caspase nine (TUCAN) polypeptides; monitoring success of treatments with antitumor agents |
| 01/16/2007 | US7163797 50 human secreted proteins |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/16/2007 | US7163701 Therapy for nervous system disorders; administering nerve growth factor |
| 01/16/2007 | US7163698 Complex of drug and polyester |
| 01/16/2007 | US7163695 Histidine copolymer and methods for using same |
| 01/16/2007 | US7163686 Protein A based binding domains with desirable activities |
| 01/16/2007 | US7163684 Method of increasing bone toughness and stiffness and reducing fractures |
| 01/16/2007 | US7163683 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 01/16/2007 | US7163682 For inducing antibody production against Streptococcal antigens |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | US7163671 Stable protein formulation containing tryptophan or a tryptophan derivative or a salt thereof as a stabilizer; storage stability of hematopoietic factors such as erythropoietin |
| 01/16/2007 | CA2484724C Pharmaceutical formulations |
| 01/16/2007 | CA2293682C Stable particle in liquid formulations |
| 01/16/2007 | CA2253412C Microparticles and their use in wound therapy |
| 01/16/2007 | CA2252055C Fusogenic liposomes |
| 01/16/2007 | CA2232240C Peptide for inhibiting growth of smooth muscle cells |
| 01/16/2007 | CA2168963C Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 01/16/2007 | CA2103996C Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 01/11/2007 | WO2007006041A2 Imaging and therapeutic method using monocytes |
| 01/11/2007 | WO2007005995A2 Compositions for buccal delivery of human growth hormone |
| 01/11/2007 | WO2007005990A2 Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke |
| 01/11/2007 | WO2007005867A2 Compositions and methods for providing a graded response in a protein |
| 01/11/2007 | WO2007005856A1 Use of hyaluronidase in combination with plasmin for the induction of posterior vitreous detachment |
| 01/11/2007 | WO2007005838A2 Hcv inhibitors |
| 01/11/2007 | WO2007005766A1 Genomic nucleic acid sequence for cyanovirin-n and signal peptide thereof |
| 01/11/2007 | WO2007005738A2 Glp-1 pharmaceutical compositions |
| 01/11/2007 | WO2007005733A2 Novel peptides promoting neurite outgrowth |
| 01/11/2007 | WO2007005620A2 Arginase ii: a target treatment of aging heart and heart failure |
| 01/11/2007 | WO2007005389A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 01/11/2007 | WO2007005359A1 Composition and method for producing stable amyloid beta oligomers of high molecular weight |
| 01/11/2007 | WO2007005320A2 Methods of delivering corticotroph-derived glycoprotein hormone |
| 01/11/2007 | WO2007005300A2 Treatment of dry eye |
| 01/11/2007 | WO2007005244A1 Henipavirus receptor and uses thereof |
| 01/11/2007 | WO2007005027A1 Identification of non-small cell lung carcinoma (nsclc) tumors expressing pdgfr-alpha |
| 01/11/2007 | WO2007004979A1 Method for modulating responsiveness to steroids |
| 01/11/2007 | WO2007004977A1 Immunostimulatory method |
| 01/11/2007 | WO2007004876A2 Peptides inhibiting angiotensin-converting enzyme |
| 01/11/2007 | WO2007004692A1 Prophylactic/therapeutic agent and diagnostic agent for non-small cell lung cancer |
| 01/11/2007 | WO2007004587A1 Malignant tumor cell suppressor protein, malignant tumor cell suppressor gene, malignant tumor cell suppressive viral vector, and kit using the same |
| 01/11/2007 | WO2007004526A2 Identification of compounds modulating the smyd3 transferase for the treatment of cancer |
| 01/11/2007 | WO2007004510A1 Pharmaceutical for use in the treatment of cerebral infarction |
| 01/11/2007 | WO2007004341A1 Rna-binding peptide |
| 01/11/2007 | WO2007004325A1 Protein preparation containing s1-5 |
| 01/11/2007 | WO2007003958A2 Methods for tissue engineering |
| 01/11/2007 | WO2007003941A1 Modulation of autophagy by calpain inhibition |
| 01/11/2007 | WO2007003054A1 Method of biomolecule immobilization on polymers using click-type chemistry |
| 01/11/2007 | WO2007003033A1 Methods and compositions for enhancing developmental potential of oocytes and preimplantation embryos |
| 01/11/2007 | WO2007003010A1 Anticoagulation agent and uses thereof |
| 01/11/2007 | WO2006128190A3 Compositions and methods for treatment of neural disorders using transforming growth factor-beta superfamily proteins and their antagonists |
| 01/11/2007 | WO2006128176A3 Composite molecules comprising g-csf function |
| 01/11/2007 | WO2006121700A3 Hydratable keratin compositions |
| 01/11/2007 | WO2006117565A3 Glucagon-like-peptide-2 (glp-2) analogues |
| 01/11/2007 | WO2006108818A3 Trimeric peptides for use in treating obesity |
| 01/11/2007 | WO2006107945A3 Use of rip in treating staphylococcus aureus infections |
| 01/11/2007 | WO2006106519A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 01/11/2007 | WO2006105527A3 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 01/11/2007 | WO2006103206A3 Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis |
| 01/11/2007 | WO2006096829A3 Thyrotropin-releasing hormone analogs and method of use |
| 01/11/2007 | WO2006094269A3 Anti-angiogenic compounds |
| 01/11/2007 | WO2006086012A3 Antibiotic compound |
| 01/11/2007 | WO2006085033A3 Pharmaceutical compositions for the treatment of prostate cancer |
| 01/11/2007 | WO2006074390A3 Methods of treating obesity with combination therapeautics of igf-i fusion polypeptides |
| 01/11/2007 | WO2006071274A3 Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer’s disease |
| 01/11/2007 | WO2006052468A3 Adrenocorticotropic hormone analogs and related methods |